slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38,98 CNY | +2,36% | -0,10% | -18,79% |
01/03 | De winst van BGI Genomics in 2023 daalt met 89% terwijl de omzet met 38% daalt | MT |
29/02 | BGI Genomics Co, Ltd. Rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023 | CI |
Vakgebied
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Comprehensive Solutions for Precision Medical Testing
32,4
%
| 2 504 | 35,5 % | 1 407 | 32,4 % | -43,79% |
Reproductive Health Basic Research and Clinical Application
27,1
%
| 1 116 | 15,8 % | 1 178 | 27,1 % | +5,55% |
Multi-omics Big Data Service and Synthetic
16,3
%
| 705 | 10,0 % | 707 | 16,3 % | +0,33% |
Cancer and Chronic Disease Prevention and Control and Translational Medicine
12,1
%
| 404 | 5,7 % | 525 | 12,1 % | +30,07% |
Infection Prevention and Control Basic Research and Clinical Application
11,9
%
| 2 301 | 32,7 % | 516 | 11,9 % | -77,59% |
Other
0,4
%
| 17 | 0,2 % | 17 | 0,4 % | +1,42% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China (Excluding Hong Kong, Macau and Taiwan)
79,5
%
| 3 622 | 51,4 % | 3 459 | 79,5 % | -4,50% |
Asia (Including Hong Kong, Macau and Taiwan) and Oceania
12,8
%
| 2 791 | 39,6 % | 558 | 12,8 % | -80,02% |
Europe and Africa
5,0
%
| 389 | 5,5 % | 217 | 5,0 % | -44,20% |
Americas
2,7
%
| 245 | 3,5 % | 116 | 2,7 % | -52,53% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Jian Zhao
CEO | Chief Executive Officer | - | 16-06-21 |
Jian Hua Wang
FOU | Founder | 70 | - |
Yu Jue Wang
DFI | Director of Finance/CFO | 46 | 16-06-21 |
Yu Tao Du
COO | Chief Operating Officer | 47 | 19-06-18 |
Ye Yin
BRD | Director/Board Member | 45 | - |
Li Ping Ao
IRC | Investor Relations Contact | - | - |
Qian Xu
SEC | Corporate Secretary | 40 | 22-06-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jian Hua Wang
FOU | Founder | 70 | - |
Hong Tao Wang
BRD | Director/Board Member | - | 29-03-16 |
Ye Yin
BRD | Director/Board Member | 45 | - |
- | - | ||
Yu Jie Hu
BRD | Director/Board Member | 40 | 22-06-15 |
Yu Tao Du
COO | Chief Operating Officer | 47 | 19-06-18 |
Lan Du
BRD | Director/Board Member | 48 | 13-08-21 |
Si Qi Liu
CHM | Chairman | 71 | 16-06-21 |
Ya Cao
BRD | Director/Board Member | 73 | 16-06-21 |
Li Jian Zhao
CEO | Chief Executive Officer | - | 16-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 417 914 466 | 215 943 776 ( 51,67 %) | 4 000 141 ( 0,9572 %) | 51,67 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
BANGKOK GENOMICS INNOVATION 37.40% | 224 400 000 | 37.40% | 20 786 172 $ |
1 065 173 | 1.28% | 4 086 813 $ |
Bedrijfsgegevens
BGI Genomics Co., Ltd.
7/F, North Building, Xinhuadu Bldg 162 Wusi Road
350003, Fuzhou
+
http://www.genomics.cnSector
Verkoop per activiteit
Verkoop per regio
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,79% | 2,04 mld. | |
-12,99% | 11,33 mld. | |
+42,00% | 3,16 mld. | |
-32,79% | 2,14 mld. | |
-25,34% | 1,49 mld. | |
+21,83% | 975 mln. | |
-4,37% | 731 mln. | |
-27,33% | 423 mln. | |
+26,64% | 371 mln. | |
-44,49% | 364 mln. |
- Beurs
- Aandelen
- Koers 300676
- Onderneming BGI Genomics Co., Ltd.